Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,166 USD | -3,62% | -3,62% | -62,62% |
Vakgebied
Aantal werknemers: 11
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jacques Suzanne
CEO | Chief Executive Officer | 53 | 28-03-22 |
Founder | 79 | 01-09-15 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 19-07-23 |
Miles Nunn
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-15 |
John Neylan
CTO | Chief Tech/Sci/R&D Officer | 70 | 08-11-22 |
Chief Operating Officer | - | 01-07-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 01-06-16 |
Founder | 79 | 01-09-15 | |
Director/Board Member | 61 | 05-07-23 | |
Samir R. Patel
BRD | Director/Board Member | 55 | 29/11 |
Director/Board Member | 70 | 23-01-18 | |
Jacques Suzanne
CEO | Chief Executive Officer | 53 | 28-03-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 13 234 315 298 | 3 808 858 604 ( 28,78 %) | 0 | 28,78 % |
Bedrijfsgegevens
Akari Therapeutics Plc
22 Boston Wharf Road 7th Floor
02210, Boston
+44 20 8004 0270
http://www.akaritx.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-62,62% | 9,59 mln. | |
-3,10% | 102 mld. | |
+2,11% | 96,07 mld. | |
-1,80% | 21,66 mld. | |
-17,75% | 20,77 mld. | |
-6,91% | 18,53 mld. | |
-42,00% | 16,91 mld. | |
-28,19% | 13,79 mld. | |
+0,18% | 13,33 mld. | |
+19,90% | 10,94 mld. |
- Beurs
- Aandelen
- Koers AKTX
- Onderneming Akari Therapeutics, Plc